Jan. 17 -- FRIDAY, Jan. 16 (HealthDay News) -- The U.S. Food and Drug Administration has approved Riastap to treat a blood disorder caused by a rare genetic condition. The disorder, congenital ...
The FDA has approved RiaSTAP(purified fibrinogen concentrate, from CSL Behring) for the treatment of acutebleeding episodes in patients with congenital fibrinogen deficiency, includingafibrinogenemia ...
(Reuters) – Two proposed therapies to treat rare blood disorders appear safe and effective for U.S. approval, Food and Drug Administration staff reviewers said in documents released Wednesday. CSL Ltd ...
WASHINGTON, Jan. 20 (UPI) -- The U.S. Food and Drug Administration has approved RiaSTAP for the treatment of bleeding in patients with a rare genetic defect. People with the defect -- congenital ...
WASHINGTON, Jan 7 (Reuters) - Two proposed therapies to treat rare blood disorders appear safe and effective for U.S. approval, including one made from genetically engineered goats, Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results